Atopic Dermatitis Clinical Trials in Detroit, Michigan

3 studies are recruiting for atopic dermatitis in Detroit, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

    This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an APG777 Parent Study (NCT06395948). The LTE study will consist of 3 periods: 1) Screening Visit will …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Investigational Site, Detroit, Michigan
    Locations
    71 in total
    Run by
    Apogee Therapeutics, Inc.

    See if you can join NCT07003425 on ClinicalTrials.gov

  2. This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

    The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. …

    Stage
    Not phased
    Ages
    12 and older
    Site
    Wayne State University - Detroit Medical Center- Site Number : 8400035, Detroit, Michigan
    Locations
    79 in total
    Run by
    Sanofi

    See if you can join NCT07290803 on ClinicalTrials.gov

  3. A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy an…

    Stage
    Phase 3
    Ages
    18 to 63
    Site
    Henry Ford Medical Center - New Center One /ID# 263522, Detroit, Michigan
    Locations
    128 in total
    Run by
    AbbVie

    See if you can join NCT06389136 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.